Establishing secure connection…Loading editor…Preparing document…

Legal Triple I Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

LEGAL TRIPLE I AGREEMENT

This Legal Triple I Agreement ("Agreement") is made and entered into as of , by and between Party A Name: , an entity of type , with principal address ; and Party B Name: , an entity of type , with principal address .

RECITALS

WHEREAS, Party A possesses certain confidential information, technical data and trade secrets and may disclose such Information to Party B in connection with the project described as ; and

WHEREAS, Party B may create or contribute to inventions, improvements and tangible embodiments related to the foregoing during the term of this Agreement; and

WHEREAS, the parties intend to set forth their respective obligations with respect to Information, Inventions and Indemnity (collectively, the "Triple I Obligations").

NOW THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the parties agree as follows:

1. DEFINITIONS

1.1 "Information" means all confidential, proprietary, technical or business information disclosed by either party, whether or not marked confidential, including specifications, designs, formulas, financial data and business plans.

1.2 "Invention" means any invention, discovery, improvement, process, software, design, or work of authorship, whether or not patentable or copyrightable, conceived, developed or reduced to practice by Party B alone or jointly with others in the course of performance under this Agreement.

1.3 "Indemnified Claims" means losses, liabilities, damages, costs and expenses (including reasonable attorneys' fees) arising from third-party claims caused by a breach of this Agreement, infringement of intellectual property rights, or willful misconduct.

2. CONFIDENTIALITY OF INFORMATION

2.1 Nondisclosure. Each party shall hold Information of the other party in strict confidence and shall not disclose such Information except to employees, contractors or agents who have a need to know and who are subject to confidentiality obligations at least as protective as those set forth in this Agreement.

2.2 Permitted Disclosures. The foregoing obligations shall not apply to information that: (a) is or becomes public through no fault of the receiving party; (b) was rightfully known by the receiving party prior to disclosure; (c) is rightfully received from a third party without restriction; or (d) is independently developed by the receiving party without reference to the disclosing party's Information.

2.3 Return or Destruction. Upon termination of this Agreement or upon written request, the receiving party shall promptly return or destroy, at the disclosing party's election, all tangible manifestations of Information and certify in writing as to such destruction.

3. INVENTIONS; ASSIGNMENT OF RIGHTS

3.1 Assignment. Party B hereby assigns and agrees to assign to Party A all right, title and interest in and to any Invention conceived or reduced to practice, in whole or in part, during the term of this Agreement that relates to Party A's business or Information or that results from services performed under this Agreement.

3.2 Cooperation. Party B shall, at Party A's request and expense, execute and deliver such assignments, patent applications, declarations and other instruments as reasonably required to effectuate the foregoing assignment and to obtain, maintain and enforce intellectual property protection.

3.3 Moral Rights. To the extent permitted by applicable law, Party B hereby irrevocably waives and agrees not to assert any moral rights or other non-economic rights with respect to any Invention assigned under this Agreement.

4. INDEMNIFICATION

4.1 Indemnification by Party B. Party B shall indemnify, defend and hold harmless Party A and its officers, directors and affiliates from and against any Indemnified Claims to the extent arising out of: (a) a breach by Party B of its representations, warranties or obligations under this Agreement; (b) any claim that Party B's activities or deliverables infringe or misappropriate a third party's intellectual property rights; or (c) Party B's gross negligence or willful misconduct.

4.2 Defense and Settlement. The indemnifying party shall control the defense and settlement of any Indemnified Claim, provided that no settlement that imposes liability or injunctive relief on the indemnified party may be entered into without the indemnified party's prior written consent, which shall not be unreasonably withheld.

5. REPRESENTATIONS AND WARRANTIES

5.1 Mutual Representations. Each party represents and warrants that it has the full corporate or individual power and authority to enter into this Agreement and to perform its obligations hereunder.

5.2 Additional Warranty by Party B. Party B warrants that, to the best of its knowledge, any deliverable provided to Party A under this Agreement will not infringe the intellectual property rights of any third party.

6. TERM; TERMINATION; SURVIVAL

6.1 Term. This Agreement shall commence on the Effective Date and continue for a period of unless earlier terminated in accordance with this Section.

6.2 Termination for Cause. Either party may terminate this Agreement upon written notice if the other party materially breaches any obligation and fails to cure such breach within thirty (30) days after receipt of written notice.

6.3 Survival. Sections relating to Confidentiality, Assignment of Inventions, Indemnification, Governing Law, Severability and Entire Agreement shall survive termination or expiration of this Agreement.

7. REMEDIES; INJUNCTIVE RELIEF

7.1 Remedies. The parties agree that money damages may be an inadequate remedy for breach of confidentiality or assignment obligations and that the non-breaching party shall be entitled to seek injunctive or equitable relief in addition to any other remedies available at law or in equity.

8. LIMITATION OF LIABILITY

Except for liability arising from willful misconduct, gross negligence, or a party's breach of Sections 2 (Confidentiality), 3 (Inventions) or 4 (Indemnification), neither party shall be liable to the other for indirect, incidental, special or consequential damages, provided that aggregate direct damages shall be limited to the fees paid or payable under this Agreement during the twelve (12) months preceding the claim.

9. NOTICES

Notices to Party A

Notices to Party B

10. AMENDMENT; WAIVER; COUNTERPARTS

10.1 Amendment. This Agreement may be amended only by a writing executed by authorized representatives of both parties.

10.2 Waiver. No failure or delay by either party in exercising any right shall operate as a waiver of that right unless a written waiver is executed.

10.3 Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original and all of which together shall constitute one instrument.

11. GOVERNING LAW; VENUE

This Agreement shall be governed by and construed in accordance with the laws of , without regard to conflicts of law principles. The parties agree that the state and federal courts located in the chosen jurisdiction shall have exclusive venue for disputes arising under this Agreement, subject to equitable relief as provided herein.

12. ENTIRE AGREEMENT; SEVERABILITY

12.1 Entire Agreement. This Agreement, including any schedules or exhibits attached hereto, constitutes the entire agreement between the parties with respect to the subject matter and supersedes all prior and contemporaneous agreements, understandings and communications, whether written or oral.

12.2 Severability. If any provision of this Agreement is held invalid or unenforceable, such provision shall be modified to the minimum extent necessary to make it enforceable; if modification is not possible, the invalid or unenforceable provision shall be severed and the remaining provisions shall remain in full force and effect.

ADDITIONAL PROVISIONS

13.1 Assignment. Neither party may assign this Agreement without the other party's prior written consent, except that either party may assign to an affiliate or successor to substantially all of its business.

13.2 Insurance. Each party shall maintain insurance coverage customary for its industry and sufficient to cover its obligations under this Agreement.

SCOPE & EXCLUSIONS

14.1 Scope of Information. Describe scope or specific exclusions below (if none, state "None"):

14.2 Excluded Items. The following categories of information or inventions are excluded from the obligations of this Agreement:

Party A

Party Label:

By:

Date:

Party B

Party Label:

By:

Date:

Enter text✕
Prepare your document for signing right on this page
  • 01 Edit the text and complete the fields
  • 02 Click Sign Now and on the next screen add recipients and signature fields in SignNow
  • 03 Start your free trial to sign and send your doc
Sign Now

What the Legal Triple I Agreement Is and when it applies

The Legal Triple I Agreement is a written contract used to document identity, intent, and issuance terms between parties for regulatory or transactional purposes. It sets out parties' legal names, scope of authorization, dates of effect, and any required attestations or certifications. Commonly used where verification of identity and explicit intent to be bound are essential, it clarifies obligations, limits liability, and records any permitted disclosures or third-party access. The form supports both paper and electronic execution and can be adapted with addenda for industry-specific requirements.

Why the Legal Triple I Agreement matters and its legal standing

The agreement documents identity, intent to sign, and issuance terms to reduce disputes and demonstrate compliance with applicable law; when executed correctly it creates clear contractual obligations and evidentiary value under federal and state e‑signature frameworks, including the ESIGN Act (15 U.S.C. ch. 96) and UETA.

Why the Legal Triple I Agreement matters and its legal standing

Typical parties and roles that complete this agreement

The Legal Triple I Agreement is used by organizations and individuals who must verify identity and intent before granting rights, credentials, or regulated access.

  • Corporate Compliance Teams ensuring authorized signatory identity for contracts and certificates.
  • Healthcare Administrators verifying identity and consent for regulated disclosures.
  • Financial Services staff confirming signer identity for account openings and high‑risk transactions.

Use varies by industry and by internal policy; include the correct signer type and authentication level to match regulatory or contractual risk profiles.

Core parts of a compliant Legal Triple I Agreement

A complete agreement combines identification data, a clear statement of intent, issuance details, authentication steps, governing law, and signature blocks tailored to execution method.

Identification

Full legal names, government ID details, and contact information for each party to establish an auditable link to the signer and reduce identity disputes in future enforcement.

Intent Clause

A concise statement confirming the signer's intent to be bound by the agreement and consent to electronic records where applicable, satisfying ESIGN/UETA evidence requirements.

Issuance Terms

Specific rights, obligations, effective date, duration, and any limitations or conditions describing what is being issued and under what authority.

Authentication Log

Record of identity verification steps (ID type, verification method, IP, timestamp) to support attribution and defensibility of the electronic signature event.

Governing Law

Choice of law and venue clauses identifying which state’s statutes interpret the agreement and where disputes will be resolved.

Signature Block

Designated fields for signer name, title, date, and witness/notary fields where required; specify electronic signing method if used.

Essential fields to include

Party Name: Exactly as on ID
Date of Birth: MM/DD/YYYY
ID Type: Driver's license, passport
Effective Date: MM/DD/YYYY
Governing State: State name
Signature Method: eSign or notarized

Step-by-step: completing the Legal Triple I Agreement

Follow these sequential steps to prepare, verify, and finalize the agreement with clear records of identity and intent.

  • 01
    Prepare Document: Populate parties, terms, and effective date.
  • 02
    Attach IDs: Collect scans or photos of required identity documents.
  • 03
    Verify Identity: Use KBA, ID analysis, or in‑person verification.
  • 04
    Execute: Sign, notarize if required, and record audit trail.

Configuring an online workflow for completion

Set fields, authentication, and routing to match your compliance and audit requirements before sending for signature.

Field Configuration
Signature Type Electronic or notarized per risk level
Authentication Email, SMS code, or KBA
Conditional Fields Show or hide fields based on answers
Retention Policy Automatic archive and export settings

Where to send or file the completed agreement

Routing depends on whether the agreement requires internal review, public filing, or third‑party verification; follow the required sequence.

  • Internal Records: Store executed copies in your contract repository.
  • Notary Submission: Provide original to notary for acknowledgement when required.
  • Regulatory Filing: File with the designated agency if statute mandates.
  • Counterpart Distribution: Send signed counterparts to all parties and retain one master copy.

Digital signing and technical requirements

Ensure your signing platform supports the authentication and retention features required for the agreement.

  • Document Formats: PDF, DOCX supported
  • Authentication Methods: Email, SMS, KBA available
  • Audit Trail: IP, timestamp, action log

Choose a platform that records a tamper‑evident audit trail, supports required integrations (CRM, storage), and can meet regulatory needs such as HIPAA or 21 CFR Part 11 when applicable.

Key timelines and response deadlines to track

Track effective, review, and notice deadlines to maintain enforceability and meet contractual or regulatory requirements.

Effective Date:

Date when rights and obligations begin

Review Period:

Typical 7–30 day internal review window

Signature Deadline:

Date by which all parties must sign

Notary Timing:

Complete notarization before filing or recording

Record Retention Start:

Begins on execution or final effective date

Typical processing milestones from draft to execution

A clear milestone sequence helps teams coordinate verification, approvals, and final signing without missing critical steps.

01

Draft Completed

Terms finalized and fields placed for signer review.

02

Identity Verification

ID checks, KBA, or in‑person confirmation completed.

03

Approval Signatures

Authorized signers provide signatures in required order.

04

Finalization

Notarization (if needed), distribution, and secure archiving.

Common mistakes to avoid when preparing this agreement

  • Submitting mismatched names or inconsistent dates that require re‑execution and delay enforcement.
  • Using insufficient authentication for high‑risk transactions, weakening attribution and evidentiary value.
  • Failing to include governing law or jurisdiction clauses, which can complicate dispute resolution.
  • Not retaining a complete audit trail or original signed copy, leaving gaps in proof of execution.

Consequences and legal risks of errors

Contract Invalidity: Agreement may be unenforceable
Regulatory Fines: Penalties for noncompliance
Liability Exposure: Increased breach risk
Delayed Transactions: Operational and financial delays
Reputational Harm: Loss of stakeholder trust
Recordkeeping Violations: Possible statutory penalties

Real-world examples of when the Legal Triple I Agreement is used

These short examples show typical scenarios where identity, intent, and issuance tracking are essential.

Real Estate Closing

A title company requires verified signer identity before issuing closing funds.

  • The company logs ID type and timestamp.
  • The recorded agreement prevents future challenges to authority and supports title insurance underwriting for the transaction.

Healthcare Release

A clinic collects signed authorization to share patient records with a specialist.

  • The signer’s identity is verified and consent is time‑stamped.
  • The complete file, including audit trail, supports HIPAA compliance and documents patient consent for disclosure.

Who typically signs and approves this agreement

Authorized Signer — Corporate

A named officer or agent with delegated authority signs on behalf of the organization; include title and source of delegation (board resolution or power of attorney) to clarify authority.

Individual Signer — Consumer

An individual who must present government ID and consent to electronic records when consumer protections apply; include disclosure of rights under ESIGN when required.

Selected eSignature vendor comparison for executing the agreement

Basic pricing and capability differences among common eSignature providers; signNow appears first per comparison conventions.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial Yes, 7-day trial Yes, 30-day trial Yes, trial available Yes, limited Yes, limited
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
Envelope Cap No cap 100 envelopes/user/year Varies by plan Varies by plan Varies by plan

Frequently asked questions and troubleshooting tips

Common questions about execution, enforceability, and digital workflows are answered here to reduce implementation friction and ensure compliant records.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users
Sign Now
Company
Forms
Pricing
Resources
Knowledge base
Other Products
© 2026 airSlate Inc. All rights reserved.